Search results:

Gene ID	Symbol	Synonyms	Official Full Name	Location
The pahtway p176 has 54 genes in the original annotation. Currently, there are 47 genes in SZGR (with evidence in schizophrenia) that are present at this pathway.
3265	HRAS	C-BAS/HAS \| C-H-RAS \| C-HA-RAS1 \| CTLO \| H-RASIDX \| HAMSV \| HRAS1 \| RASH1 \| p21ras	Harvey rat sarcoma viral oncogene homolog	11p15.5
595	CCND1	BCL1 \| D11S287E \| PRAD1 \| U21B31	cyclin D1	11q13
3845	KRAS	C-K-RAS \| CFC2 \| K-RAS2A \| K-RAS2B \| K-RAS4A \| K-RAS4B \| KI-RAS \| KRAS1 \| KRAS2 \| NS \| NS3 \| RALD \| RASK2	Kirsten rat sarcoma viral oncogene homolog	12p12.1
1019	CDK4	CMM3 \| PSK-J3	cyclin-dependent kinase 4	12q14
5925	RB1	OSRC \| PPP1R130 \| RB \| p105-Rb \| pRb \| pp110	retinoblastoma 1	13q14.2
6655	SOS2	NS9	SOS Ras/Rho guanine nucleotide exchange factor 2	14q21
207	AKT1	AKT \| CWS6 \| PKB \| PKB-ALPHA \| PRKBA \| RAC \| RAC-ALPHA	v-akt murine thymoma viral oncogene homolog 1	14q32.32
5604	MAP2K1	CFC3 \| MAPKK1 \| MEK1 \| MKK1 \| PRKMK1	mitogen-activated protein kinase kinase 1	15q22.1-q22.33
5579	PRKCB	PKC-beta \| PKCB \| PRKCB1 \| PRKCB2	protein kinase C beta	16p11.2
5595	MAPK3	ERK-1 \| ERK1 \| ERT2 \| HS44KDAP \| HUMKER1A \| P44ERK1 \| P44MAPK \| PRKM3 \| p44-ERK1 \| p44-MAPK	mitogen-activated protein kinase 3	16p11.2
5336	PLCG2	APLAID \| FCAS3 \| PLC-IV \| PLC-gamma-2	phospholipase C gamma 2	16q24.1
23533	PIK3R5	F730038I15Rik \| FOAP-2 \| P101-PI3K \| p101	phosphoinositide-3-kinase regulatory subunit 5	17p13.1
7157	TP53	BCC7 \| LFS1 \| P53 \| TRP53	tumor protein p53	17p13.1
2064	ERBB2	CD340 \| HER-2 \| HER-2/neu \| HER2 \| MLN 19 \| NEU \| NGL \| TKR1	erb-b2 receptor tyrosine kinase 2	17q12
2885	GRB2	ASH \| EGFRBP-GRB2 \| Grb3-3 \| MST084 \| MSTP084 \| NCKAP2	growth factor receptor bound protein 2	17q24-q25
5578	PRKCA	AAG6 \| PKC-alpha \| PKCA \| PRKACA	protein kinase C alpha	17q24.2
5605	MAP2K2	CFC4 \| MAPKK2 \| MEK2 \| MKK2 \| PRKMK2	mitogen-activated protein kinase kinase 2	19p13.3
208	AKT2	HIHGHH \| PKBB \| PKBBETA \| PRKBB \| RAC-BETA	v-akt murine thymoma viral oncogene homolog 2	19q13.1-q13.2
5296	PIK3R2	MPPH \| MPPH1 \| P85B \| p85 \| p85-BETA	phosphoinositide-3-kinase regulatory subunit 2	19q13.2-q13.4
4893	NRAS	ALPS4 \| CMNS \| N-ras \| NCMS \| NRAS1 \| NS6	neuroblastoma RAS viral (v-ras) oncogene homolog	1p13.2
8503	PIK3R3	p55 \| p55-GAMMA \| p55PIK	phosphoinositide-3-kinase regulatory subunit 3	1p34.1
1870	E2F2	E2F-2	E2F transcription factor 2	1p36
5293	PIK3CD	APDS \| IMD14 \| P110DELTA \| PI3K \| p110D	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta	1p36.2
842	CASP9	APAF-3 \| APAF3 \| ICE-LAP6 \| MCH6 \| PPP1R56	caspase 9	1p36.21
6258	RXRG	NR2B3 \| RXRC	retinoid X receptor gamma	1q22-q23
83593	RASSF5	Maxp1 \| NORE1 \| NORE1A \| NORE1B \| RAPL \| RASSF3	Ras association domain family member 5	1q32.1
10000	AKT3	MPPH \| MPPH2 \| PKB-GAMMA \| PKBG \| PRKBG \| RAC-PK-gamma \| RAC-gamma \| STK-2	v-akt murine thymoma viral oncogene homolog 3	1q44
6789	STK4	KRS2 \| MST1 \| TIIAC \| YSK3	serine/threonine kinase 4	20q11.2-q13.2
5335	PLCG1	NCKAP3 \| PLC-II \| PLC1 \| PLC148 \| PLCgamma1	phospholipase C gamma 1	20q12-q13.1
5594	MAPK1	ERK \| ERK-2 \| ERK2 \| ERT1 \| MAPK2 \| P42MAPK \| PRKM1 \| PRKM2 \| p38 \| p40 \| p41 \| p41mapk \| p42-MAPK	mitogen-activated protein kinase 1	22q11.21
7039	TGFA	TFGA	transforming growth factor alpha	2p13
2272	FHIT	AP3Aase \| FRA3B	fragile histidine triad	3p14.2
11186	RASSF1	123F2 \| NORE2A \| RASSF1A \| RDA32 \| REH3P21	Ras association domain family member 1	3p21.3
5915	RARB	HAP \| MCOPS12 \| NR1B2 \| RRB2	retinoic acid receptor beta	3p24.2
5894	RAF1	CMD1NN \| CRAF \| NS5 \| Raf-1 \| c-Raf	Raf-1 proto-oncogene, serine/threonine kinase	3p25
5291	PIK3CB	P110BETA \| PI3K \| PI3KBETA \| PIK3C1	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta	3q22.3
5290	PIK3CA	CLOVE \| CWS5 \| MCAP \| MCM \| MCMTC \| PI3K \| p110-alpha	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha	3q26.3
1950	EGF	HOMG4 \| URG	epidermal growth factor	4q25
5295	PIK3R1	AGM7 \| GRB1 \| IMD36 \| p85 \| p85-ALPHA	phosphoinositide-3-kinase regulatory subunit 1	5q13.1
6257	RXRB	DAUDI6 \| H-2RIIBP \| NR2B2 \| RCoR-1	retinoid X receptor beta	6p21.3
1871	E2F3	E2F-3	E2F transcription factor 3	6p22
2309	FOXO3	AF6q21 \| FKHRL1 \| FKHRL1P2 \| FOXO2 \| FOXO3A	forkhead box O3	6q21
1956	EGFR	ERBB \| ERBB1 \| HER1 \| NISBD2 \| PIG61 \| mENA	epidermal growth factor receptor	7p12
1021	CDK6	MCPH12 \| PLSTIRE	cyclin-dependent kinase 6	7q21-q22
673	BRAF	B-RAF1 \| BRAF1 \| NS7 \| RAFB1	B-Raf proto-oncogene, serine/threonine kinase	7q34
1029	CDKN2A	ARF \| CDK4I \| CDKN2 \| CMM2 \| INK4 \| INK4A \| MLM \| MTS-1 \| MTS1 \| P14 \| P14ARF \| P16 \| P16-INK4A \| P16INK4 \| P16INK4A \| P19 \| P19ARF \| TP16	cyclin-dependent kinase inhibitor 2A	9p21
6256	RXRA	NR2B1	retinoid X receptor alpha	9q34.3